The transEAsome project

1 November 2022
Led by the CRACMO*, the TransEAsome project provides the long term follow-up of children operated from esophageal atresia until they are 13-14 years old.

In addition to monitoring, a biobank will be incorporated with esophageal biopsies performed during endoscopies and blood tests, in order to detect protein and epigenetic markers to allow prediction of future disease.

This project has received funding from the Agence Nationale de la Recherche program France 2030 under a specific grant agreement.

AFAO, The French family support group, is part of the TransEAsome project.

*CRACMO is the French Reference Center for Congenital Esophageal abnormalities. It was founded in 2006 as part of the National Rare Disease Charter and is based in Lille University Hospital. This hospital has vast experience in surgery and multidisciplinary follow up of EA patients.

Prospective cohort of adolescents born with esophageal atresia in order to assess the long-term health outcome #TransEAsome

Leave a Reply

Your email address will not be published.